The human T-cell leukemia/lymphoma virus (HTLV) genome, in addition to the structural Gag and Env proteins and retroviral enzymes, carries a region at its 3 0 end originally designated pX. To date, we know that this region encodes two essential transcriptional and posttranscriptional positive regulators of viral expression, the Tax and Rex proteins, respectively (reviewed elsewhere in this issue). Here, we will review current knowledge of the functions of three additional proteins encoded in the pX region, p12 I , p13 
Introduction
Almost 10 years after the discovery of HTLV-1 and Tax and Rex proteins, additional alternatively spliced viral mRNAs were described (Berneman et al., 1992; Ciminale et al., 1992; Koralnik et al., 1992a) (Figure 1 ). The proteins encoded by these alternatively spliced mRNAs were named p12 I , p30 II , and p13 II according to their apparent sizes in SDS-PAGE and the open reading frame (ORF) in which they are encoded (ORFs I and II) . In contrast to Tax and Rex, whose ablation results in severe impairment of viral replication, ablation of ORFs I and II does not significantly affect viral replication in vitro. While the expression of mRNAs for these proteins is well-documented in vitro and ex vivo, their detection in infected cells has remained elusive. However, a body of evidence suggests that these proteins may be essential for viral persistence inasmuch as ablation of ORFs I and II from molecular clones compromises the establishment of persistent infection in vivo in an animal model. Here, we will review current knowledge of the functions of p12 I , p13 II , and p30 II gained from biochemical studies in which the proteins were ectopically expressed in epithelial or T cells.
HTLV-1 ORF I: p12 I , a modulator of T-cell immune functions
The pX ORF I is encoded in both a singly and doubly spliced mRNA, with the doubly spliced mRNA predicted to produce a Rex-ORF I hybrid, and the singly spliced mRNA predicted to produce a smaller protein initiating from an AUG within ORF I (Ciminale et al., 1992; Koralnik et al., 1992a) (Figure 1 ). However, expression of either cDNA in HeLa cells yields a single protein of 12 kDa (Koralnik et al., 1992a) . The singly spliced message for p12 I is produced by splicing from nucleotide 119 from the long terminal repeat (LTR) to the splice acceptor at position 6383 (Ciminale et al., 1992; Koralnik et al., 1992a Koralnik et al., , 1993 . Expression of these mRNAs has been found in ex vivo samples from HTLV-1-infected individuals, in HTLV-1-infected T-cell lines, and in in vitro-infected macrophages (Koralnik et al., 1992a, b) . p12 I localizes to cellular endomembranes, particularly the ER and Golgi Johnson et al., 2001) . While p12 I is not necessary for HTLV-1 replication in vitro (Derse et al., 1997; Robek et al., 1998; Albrecht et al., 2000) , p12 I contributes to viral infectivity in vivo inasmuch as ablation of the acceptor splice acceptor site for the singly spliced mRNA is associated with decreased infectivity in rabbits (Collins et al., 1998) . Importantly, cytotoxic T-lymphocytes (CTLs) and serum from HTLV-1-infected individuals or experimentally infected rabbits have been demonstrated to recognize ORF I p12 I -derived peptides (Dekaban et al., 2000; Pique et al., 2000) , which provides critical, although indirect, evidence of the translation of ORF I in vivo.
Amino-acid sequence analysis of p12 I reveals a highly hydrophobic and structured protein. p12 I 's amino-acid sequence is highly conserved among ex vivo DNA samples of HTLV-1-infected individuals and contains four proline-rich (PXXP) Src homology 3 (SH3)-binding domains (Franchini, 1995) , a motif that has been shown to be important for interaction of proteins involved in intracellular signaling (Feller et al., 1994; Mayer, 2001) . Computer analysis also reveals a dileucine motif (DXXXLL) spanning amino-acid positions 26-31 and two transmembrane domains spanning amino-acids 12-30 and amino-acids 48-67 that encompass two leucine zipper motifs (Figure 2b ). These structural features could contribute to the membrane localization and homo-oligomerization of the protein. Indeed, Trovato et al. (1999) demonstrated that p12 I forms dimers. A lysine residue at position 88 of p12 I can be ubiquitinated, thus targeting the protein for proteasomemediated degradation; in fact, arginine substitution at this position increases the half-life of the protein from 30 min to 8 h. The p12 I lysine-88 variant was initially identified in a small number of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) patients, and more recent studies confirmed this finding and demonstrated that one out of forty asymptomatic carriers also harbored this variant (Furukawa et al., 2004; Martins et al., 2002) . The biological significance of the lysine/arginine substitution remains unclear at present.
A stretch of approximately 20 amino acids encompassing the second putative trans-membrane domain of p12 I displays 50% amino-acid identity with a portion of the bovine papillomavirus (BPV)-transforming E5 protein . This region of homology in the E5 protein contains two LFLL motifs and a glutamine residue that is critical for the transforming activity of E5 . When tested in a focus-formation assay, p12
I did not induce growth of foci when expressed alone, whereas, as expected, E5 did.
Interestingly, the ability of E5 to induce foci was dramatically increased in the presence of p12 I , raising the possibility that p12 I may cooperate with other oncogenic factors, such as Tax, and play a role in the tumorigenic activity of HTLV-1. Like the E5 protein, p12 I interacts with the 16 kDa subunit of the vacuolar ATPase Koralnik et al., 1995) , a complex that is important for the acidification of lysosomes and endosomes (Stevens and Forgac, 1997) . Although the binding of E5 to the 16 kDa subunit appears to be important in the E5-mediated transformation phenotype, no clear correlation was found between the p12 I -16K interaction and cooperative transformation with E5, suggesting that the p12 I -16K interaction may exert a different function. In human immunodeficiency virus (HIV) infection, the Nef protein's downregulation of CD4 from the cell surface has been associated with the ability of Nef to interact with the catalytic unit of the vacuolar ATPase, which may connect Nef with the endocytic pathway . Therefore, it is possible that p12 I uses this pathway to regulate surface expression of cellular proteins. p12 I has been shown to interact physically with the interleukin-2 receptor (IL-2R) b and g c chains and affect their surface expression (Mulloy et al., 1996) . Further studies demonstrated that p12 I binds to the cytoplasmic domain of the IL-2R b chain that is involved in the recruitment of the Janus-associated kinases Jak1 and Jak3 ( Figure 2b) . As a result of this interaction, p12 . Similarly, p12 I increases STAT5 activation in primary T cells. Upon T-cell receptor (TCR) signaling by suboptimal treatment of T cells with low concentrations of aCD3 and aCD28 antibodies and low concentration of IL-2, p12
I provides a proliferative advantage to T cells . Collectively, these data suggest that p12 I expression may decrease the threshold of T-cell activation and favor entry of T cells into the S phase even in conditions of suboptimal antigen stimulation. As is often the case with viral proteins, p12 I 's effects are not limited to the hijacking of extracellular signals. Recent studies indicate that p12 I also usurps other intracellular signaling pathways and induces a linker of activated T cells (LAT)-independent increase in intracellular calcium levels (Figure 2b ), which then signals T-cell activation (Lewis, 2001) . Furthermore, p12
I expression in Jurkat cells activated with phorbol myristyl acetate (PMA) results in activation of nuclear factor of activated T cells (NFAT)-dependent gene expression. In the same experimental conditions, AP-1-or NF-kBmediated transcription remained unaffected by p12 I Ding et al., 2001) . The finding that p12
I contains a PXIXIT calcineurin-binding motif and interacts with both calnexin and calreticulin, two ER-resident proteins that regulate calcium storage and increase calcium release, further underscores the importance of p12 I in T-cell activation Ding et al., 2001) . Indeed, p12
I modulates calcium-mediated cellular gene expression . Thus, by decreasing the threshold of T-cell activation through NFAT transcriptional activation and IL-2 production and by increasing the responsiveness to IL-2 by STAT5 activation, p12 I may amplify physiological stimulation and contribute to the proliferation of infected cells in a microenvironment where both antigens and growth factors may be limiting ( Figure 2b ). It has also been proposed that HTLV-1 p12 I may be required for optimal viral infectivity in quiescent primary cells . However, this is based on an experimental model that utilized cocultures of quiescent peripheral blood mononuclear cells (PBMCs) and fibroblasts, which themselves might have activated resting T cells through allogenic stimulation.
HTLV-1 establishes a persistent lifelong infection, suggesting that the virus has evolved measures to evade the host's immune responses. Among common strategies used by DNA and RNA viruses, recent studies suggest that HTLV-1 may have developed mechanisms to interfere with MHC presentation of viral peptides and CTL recognition as well as ways to conceal its own expression. The former function may be exerted by the p12 I protein (Figure 2c ). In contrast to HIV Nef, which downregulates MHC class I at the cell surface, p12 I binds to free MHC class I heavy chains (MHC-I-Hc) encoded by the HLA-A2, -B7, and -Cw4 alleles. Consequently, newly synthesized MHC-I-Hc fails to associate with b 2 -microglobulin and is retranslocated to the cytosol, where it is degraded by the proteasome complex. Expression of HIV Nef or HTLV-1 p12 I in virally infected cells could result in decreased expression of MHC class I on the cell surface, thereby protecting infected cells from CTL recognition. This function of p12 I may play a key role in the establishment and maintenance of infection by HTLV-1, which exhibits very low genetic variability and is capable of eliciting a strong CTL response, especially against Tax.
HTLV-1 ORF II: p30 II , a negative post-transcriptional regulator of virus expression CTL and antibodies directed against ORF II peptides can be detected in HTLV-1-infected individuals (Chen et al., 1997; Pique et al., 2000) , providing indirect evidence for translation of ORF II in HTLV-1 patients. Ablation of p30
II from a molecular clone of HTLV-1 resulted in significantly decreased viral load in a rabbit model , suggesting the importance of this ORF in HTLV-1 pathogenesis. p30 II is a mainly nucleolar protein (Figure 3 ) encoded by a doubly spliced mRNA that places the Tax AUG in frame with ORF II (Ciminale et al., 1992; Koralnik et al., 1992a) (Figure 1 ). Recent studies demonstrated that p30
II is a negative regulator of viral expression (Nicot et al., 2004) . The search for a negative regulator of HTLV-1 expression was prompted by several observations. HTLV-1 undergoes low genetic drift, decreasing the chance for the selection of viral immune escape mutants. Since, Tax is highly immunogenic and the host develops a strong cellular-and antibodymediated immune response, infected cells expressing viral proteins could be easily detected and potentially eliminated by the host's immune defenses (i.e., CTLs and antibody-dependent cellular cytotoxicity, ADCC). Hence, HTLV-1 needs to control its own expression in order to persist in an immune-competent host. In fact, analysis of freshly isolated PBMCs indicates that most HTLV-1-infected cells express low to undetectable levels of viral antigens in vivo (Gessain et al., 1991) . While this phenomenon may in part be due to epigenetic changes such as methylation of the viral promoter, other mechanisms could also be evoked, including the existence of HTLV-1 gene products that negatively I protein binds the IL-2R b between residues 330 and 350 involved in Jak1 and Jak3 recruitment, leading to an increase in STAT5 transcriptional activity. p12 I binds to newly synthesized MHC-I-Hc before its association with b 2 -microglobulin and most of the MHC class I bound to p12 I is rerouted from the Golgi to the cytosol and targeted to the proteasome for degradation, resulting in less surface expression of MHC-presenting peptide. II with an HTLV-1molecular clone (Nicot et al., 1993) does not substantially alter the levels of Gag-Pol, Env, and p21
Rex spliced mRNA in the total cellular RNA, the level of Tax/Rex mRNA is drastically reduced from the cytoplasmic RNA fraction in a p30 II dose-dependent manner. This is accompanied by nuclear accumulation of the Tax/Rex mRNA, but not the Gag-Pol or Env mRNAs, further suggesting a selective retention mechanism (Nicot et al., 2004) . In contrast to HTLV-1 Rex or HIV Rev, which bind to and facilitate the nuclearcytoplasmic export of unspliced and singly spliced viral RNA, p30
II specifically binds and retains the doubly spliced Tax/Rex mRNA in the nucleus (Figure 3) . Nicot et al., 2004) ; its apparent stable compartmentalization in the nucleus is in line with its nuclear mRNA-trapping activity. Although p30 II does not possess classical RNAbinding motifs (Figure 3) , it may bind directly to the exon-exon junction that is unique to the Tax/Rex mRNA, preventing the recruitment of cellular factors required for efficient release of the mRNA from the nuclear pore, thereby blocking mRNA export. Alternatively, p30
II may not bind RNA directly but take part in a ribonucleoprotein complex and prevent its nuclear export. Whether p30 II also affects expression of cellular mRNA is unknown and warrants further study.
Recent studies confirmed the post-transcriptional effects of p30 II on HTLV-1 replication and reported the existence of a similar regulation in HTLV-2 mediated by the p30 II homologue p28 II (Younis et al., 2004) . The fact that these human retroviruses have evolved a similar strategy to suppress their expression is an example of host adaptation that is also exploited by DNA viruses. The current model suggests that p30 II -mediated reduction of virus expression may be necessary to avoid immune recognition during viral replication and is consistent with in vivo studies showing that selective ablation of p30
II from an HTLV-1 molecular clone compromises establishment of persistent infection and results in much lower proviral loads (Silverman et al., 2004) .
Because p30 II 's primary structure contains serine-rich domains with distant homologies with several transcriptional activators, Oct-1, Oct-2, Pit-1, Engrailed, and POU-M1, it was originally proposed that it may modulate transcription of viral or cellular genes (Ciminale et al., 1992) . In fact, recent studies show that, in addition to its post-transcriptional functions, ectopically expressed p30 II differentially affects the basal level of transcription from CREB-responsive elements (CREs) and Tax-responsive elements (TREs) (Zhang et al., 2000 (Zhang et al., 2000) (Figure 3 ). Interestingly, p30
II differentially influences CREB-dependent transcription from CREs and TREs, comprised of 21 bp nucleotide repeats that contain a core CRE flanked by 5 0 and 3 0 G/C-rich sequences (Zhao and Giam, 1991; Yin and Gaynor, 1996; Zhang et al., 2000) . At low concentrations, p30 II transcriptionally activates, albeit modestly, the HTLV-1 LTR (which contains three TREs) in the absence of Tax, but represses CREBdependent transcription from CREs (Zhang et al., 2000) . In contrast, p30 II inhibits Tax-dependent LTR transactivation (Zhang et al., 2000 . The Gal4 (DBD)-p30 II fusion protein interacts with p300; likewise, HA-tagged p30 II was shown to coimmunoprecipitate with p300 and disrupt formation of Tax-p300-HTLV-1 21 bp repeat complexes in streptavidin-agarose pulldown experiments . Results of glutathione-S-transferase (GST) pull-down assays demonstrated that in vitro translated p30 II interacts with amino-acid residues 1-595 of GST-p300 and residues 451-682 of GST-CBP, which comprise the kinaseinducible exchange (KIX) domain of CBP that is known to bind to Tax (Kwok et al., 1996; Giebler et al., 1997; Harrod et al., 1998; Zhang et al., 2001; Michael et al., 2004) Recent work (Awasthi et al., 2005) demonstrated that p30 II interacts in Myc-containing transcription complexes and transactivates the human cyclin D2 promoter in a manner dependent upon TIP60 histone acetyltransferase (HAT) and the TRRAP/p434 transcriptional coactivator. A GST-p30 II fusion protein interacts with Myc in GST pull-down experiments and amino-acid residues 99-154 of p30 II bind the TIP60 HAT (Figure 3b) . Importantly, coexpression of p30 II markedly enhances Myc-dependent cellular transformation in foci-formation assays using immortalized human fibroblasts, suggesting that p30 II may possess oncogenic activity and contribute to HTLV-1 transformation. Future studies will further characterize p30 II -Myc/ TIP60 biochemical interactions and determine their roles in cell-cycle deregulation and transformation by HTLV-1. Collectively, these findings suggest that nucleolar p30 II functions as a post-transcriptional regulator of Tax/Rex mRNA (Nicot et al., 2004; Younis et al., 2004) and suggest that, through interactions with transcriptional cofactors such as p300/CBP and TIP60, p30 II may also influence RNA Pol II nucleoplasmic transcription complexes to modulate the expression of viral and cellular genes (Figure 3c ) (Zhang et al., 2000 Michael et al., 2004) .
HTLV-1 ORF II: p13
II and its interactions with the mitochondria p13 II corresponds to the 87 C-terminal amino acids of p30 II and is expressed from a singly spliced mRNA containing exons 1 and C (Ciminale et al., 1992; Koralnik et al., 1992a) (Figure 1 ). This mRNA was initially detected by RT-PCR in cell lines chronically infected with HTLV-1 as well as in adult T-cell leukemia/lymphoma (ATLL) patients (Berneman et al., 1992; Koralnik et al., 1992a) ; subsequent studies confirmed p13 II mRNA expression by RNAase protection assays (Cereseto et al., 1997) . p13 II lacks the bipartite nuclear localization signal of p30 II and is targeted primarily to mitochondria (Ciminale et al., 1999) (Figure 4a ). These are complex multifunctional organelles consisting of four major subcompartments: outer membrane, inner membrane, intermembrane space, and matrix. The fact that most mitochondrial proteins are encoded by genes in the nucleus requires a dedicated molecular machinery of receptors, translocases, and chaperones to assist the transfer of proteins from the cytoplasm to their final destination within the mitochondrion. This process is directed by the nascent protein's mitochondrial targeting sequence (MTS), which mediates interaction with the different components of the import machinery (Wiedemann et al., 2004) .
Mapping experiments carried out on p13 II led to the identification of its MTS, a short amino-proximal sequence that spans residues 21-30 (Figure 4b ). This region is predicted to form a positively charged amphipathic alpha-helix; this structure was verified by circular dichroism analysis that indicated that this folding requires exposure of the protein to membrane-like environments (e.g., phospholipid micelles). Fractionation and immuno-electron microscopy studies demonstrated that p13 II accumulates in the inner mitochondrial membrane, mainly as an integral protein (D'Agostino et al., 2002) , suggesting that p13 II might control mitochondrial membrane permeability and/or oxidative phosphorylation.
The amphipathic alpha-helical structure and aminoproximal location of the p13 II MTS is reminiscent of canonical MTS described for endogenous proteins imported in the mitochondrial inner membrane. However, the p13 II MTS is distinguished by two properties: it is not cleaved following import, and it does not require the presence of positive charges, suggesting that the protein might be imported into the organelle through alternate pathways.
Although p13 II is targeted primarily to mitochondria in the cell types tested so far (HeLa, fibroblasts, T cells) (Ciminale et al., 1999; D'Agostino et al., 2005b) (Figure 4a) , it can occasionally be detected in the Functions of HTLV-1 p12 I , p13 II , and p30 II proteins C Nicot et al nucleus . The subcellular localization of p13 II might therefore be influenced by its expression levels and the physiological status of the cell.
The search for the functional significance of p13 II has followed two main directions: analysis of the effects of p13 II at the mitochondrial level, and analysis of the impact of p13 II expression on cell function. The first evidence that p13
II might affect mitochondrial function arose from results of immunofluorescence assays of p13 II -expressing cells that showed that accumulation of p13 II in mitochondria-induced marked changes in their morphology and distribution (Ciminale et al., 1999) (Figure 4a ), suggestive of swelling and/or increased mitochondrial fission. Electron microscopy analysis of p13 II -transfected cells confirmed swelling and distension of mitochondrial cristae (D'Agostino et al., 2002) . In general, mitochondrial swelling arises as a consequence of accumulation of water in the mitochondrial matrix in response to an influx of osmotically active species, for example, due to disturbances in ion permeability. This possibility was tested by studying the direct effects of p13 II on isolated rat liver mitochondria in vitro by using synthetic peptides spanning the active portion of the protein (D'Agostino et al., 2002) . These studies showed that p13 II increases mitochondrial permeability to small monovalent cations, especially K þ , which represents the major cation in the cytoplasm of cells. The p13 II -mediated K þ current is driven by the mitochondrial transmembrane potential and may lead to mitochondrial depolarization and, at higher doses, to alteration of the Ca 2 þ uptake-release properties of mitochondria. These latter two alterations may in turn result in a lowering of the threshold for opening of the PTP, a high conductance mitochondrial channel that, when maintained in the open configuration, causes an increase in the inner mitochondrial membrane permeability to ions and solutes. This in turn causes dissipation of the mitochondrial membrane potential and diffusion, a phenomenon termed the permeability transition. The induced osmotic water flux causes passive swelling, outer membrane rupture, and release of cytochrome c from the intermembrane space to the cytoplasm, where it acts as a proapoptotic signal. These effects of p13 II on mitochondria are dependent on the presence of the arginine residues within the MTS, suggesting that this region is essential for p13 II 's function, possibly through its ability to fold and insert into the inner membrane.
A number of studies have been carried out to extend these findings to mitochondria in the context of intact cells. Analysis of cells transiently expressing p13 II mutants revealed that the ability of p13 II to induce morphological alterations in the mitochondrial network also requires the presence of the positively charged residues of the MTS, suggesting a correlation between p13 II 's in vitro ability to change K þ permeability in isolated mitochondria and its effects in intact cells.
In addition, experiments in living cells using a p13 II -GFP fusion protein revealed a mixed response, with some of the p13 II -GFP-expressing cells exhibiting mitochondrial depolarization and some others retaining mitochondrial membrane potential (Ciminale et al., 1999) . This difference did not seem to be related to the levels of expression, suggesting that p13 II 's effects on membrane potential in living cells might be modulated by additional factors such as apoptotic signaling, respiratory chain function, cell cycle, or redox potential.
Recent studies indicate that many viruses encode proteins that are targeted to mitochondria and have important effects on mitochondrial function. Consistent with the central role of mitochondria in energy production, cell death, calcium homeostasis, and redox balance, these proteins can have profound effects on host cell physiology, including cell turnover and neoplastic transformation (D'Agostino et al., 2005a) . We observed that p13 II negatively influences cell proliferation at high density in vitro and interferes with tumor growth in vivo (Silic-Benussi et al., 2004) . p13 II did not seem to trigger apoptosis 'per se' in the cell lines/ expression systems tested so far (Ciminale et al., 1999; Silic-Benussi et al., 2004) . However, p13
II was found to increase sensitivity to ceramide-induced apoptosis (SilicBenussi et al., 2004) , a pathway that is mediated through the triggering of the mitochondrial permeability transition pore (PTP) and release of proapoptotic factors by mitochondria. This finding is consistent with the effects of p13 II on membrane potential, a well characterized modulator of the PTP. The effects of p13 II on ceramidemediated apoptosis were verified in T cells, the natural target of HTLV-1 infection in vivo (D' Agostino et al., 2005b; Hiraragi et al., 2005) . These studies showed that p13 II increased the sensitivity of T cells to apoptosis induced by Fas ligand, a stimulus that is known to be mediated by activation of acidic sphingomyelinase. Interestingly, this pathway also triggers translocation of Ras to mitochondria and requires Ras farnesylation. Consistent with this model, response to FasL and the effects of p13 II are antagonized by a farnesyl transferase inhibitor . These observations are particularly interesting in light of the fact that p13 II was shown to bind to farnesyl pyrophosphate synthase, an enzyme required for the synthesis of isoprenoid precursors necessary for the farnesylation of Ras and other substrates (Lefebvre et al., 2002) .
The possibility that p13 II influences Ca 2 þ signaling is also under investigation. Although experiments aimed at directly testing intracellular Ca 2 þ homeostasis in response to p13 II have not been carried out, the effects of p13 II on mitochondrial membrane potential and Ca 2 þ retention of isolated mitochondria (D'Agostino et al., 2002) suggest that the protein might control the capacity of mitochondria to take up and release Ca 2 þ , which would in turn have profound effects on the amplitude and duration of Ca 2 þ transients following its release from the ER or capacitative entry from the extracellular medium. Consistent with this hypothesis, HeLa cells stably expressing p13
II exhibited a marked increase in Ca 2 þ -mediated phosphorylation of the CREB transcription factor (Silic-Benussi et al., 2004) . This latter effect suggests that p13 II might also influence nuclear gene expression controlled by Ca 2 þ -regulated transcription factors.
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